/BSGM
BSGM Stock - BioSig Technologies, Inc.
Healthcare|Medical - DevicesNASDAQ
$6.10+37.08%
+$1.65 (+37.08%) • Sep 11
44
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).0
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.47
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+-93.3%upside
Target: $0.41
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BSGM
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$6.04 – $6.16
TARGET (TP)$0.41
STOP LOSS$5.61
RISK/REWARD1:-11.6
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.82
52W High$14.11
52W Low$0.23
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $40,000 | $18,000 | $286,000 | $441,000 | N/A |
| Gross Profit | $40,000 | $18,000 | $229,000 | $242,000 | $-550,000 |
| Gross Margin | 100.0% | 100.0% | 80.1% | 54.9% | N/A |
| Operating Income | $-12,862,000 | $-28,512,000 | $-27,265,000 | $-33,411,000 | $-59,184,000 |
| Net Income | $-10,330,000 | $-29,041,000 | $-27,271,000 | $-31,362,000 | $-52,174,000 |
| Net Margin | -25825.0% | -161338.9% | -9535.3% | -7111.6% | N/A |
| EPS | $-0.07 | $-0.40 | $-0.63 | $-0.94 | $-1.87 |
Company Overview
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BSGMBeat Rate
20%
Last 20 quarters
Avg Surprise
-414.4%
EPS vs Estimate
Beats / Misses
4/15
1 met exactly
Latest EPS
$-0.05
Q4 2025
EPS Surprise History
Q2 24
-64.0%
$-0.82vs$-0.50
Q2 24
-24.1%
$-0.36vs$-0.29
Q3 24
-200.0%
$-0.30vs$-0.10
Q4 24
+40.0%
$-0.12vs$-0.20
Q2 25
+82.4%
$-0.03vs$-0.17
Q2 25
-180.0%
$-0.14vs$-0.05
Q3 25
-1750.0%
$-0.74vs$-0.04
Q4 25
-16.8%
$-0.05vs$-0.04
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 13, 2025 | $-0.04 | $-0.05 | -16.8% | ✗ MISS |
Q3 2025 | Aug 15, 2025 | $-0.04 | $-0.74 | -1750.0% | ✗ MISS |
Q2 2025 | May 19, 2025 | $-0.05 | $-0.14 | -180.0% | ✗ MISS |
Q2 2025 | Apr 15, 2025 | $-0.17 | $-0.03 | +82.4% | ✓ BEAT |
Q4 2024 | Nov 14, 2024 | $-0.20 | $-0.12 | +40.0% | ✓ BEAT |
Q3 2024 | Aug 14, 2024 | $-0.10 | $-0.30 | -200.0% | ✗ MISS |
Q2 2024 | May 20, 2024 | $-0.29 | $-0.36 | -24.1% | ✗ MISS |
Q2 2024 | Apr 16, 2024 | $-0.50 | $-0.82 | -64.0% | ✗ MISS |
Q4 2023 | Nov 14, 2023 | $-0.10 | $-0.60 | -500.0% | ✗ MISS |
Q3 2023 | Aug 14, 2023 | $-0.10 | $-1.60 | -1500.0% | ✗ MISS |
Q2 2023 | May 15, 2023 | $-0.10 | $-0.12 | -20.0% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | $-0.12 | $-1.40 | -1066.7% | ✗ MISS |
Q4 2022 | Nov 14, 2022 | $-1.40 | $-1.40 | 0.0% | = MET |
Q3 2022 | Aug 15, 2022 | $-1.70 | $-1.50 | +11.8% | ✓ BEAT |
Q2 2022 | May 16, 2022 | $-0.18 | $-0.22 | -22.2% | ✗ MISS |
Q1 2022 | Mar 31, 2022 | $-0.22 | $-0.24 | -9.1% | ✗ MISS |
Q4 2021 | Nov 15, 2021 | $-0.23 | $-0.21 | +8.7% | ✓ BEAT |
Q3 2021 | Aug 11, 2021 | $-0.26 | $-2.40 | -823.1% | ✗ MISS |
Q2 2021 | May 17, 2021 | $-0.15 | $-2.60 | -1633.3% | ✗ MISS |
Q1 2021 | Mar 15, 2021 | $-0.43 | $-3.10 | -620.9% | ✗ MISS |
Latest News
BioSig Technologies To Rebrand As Streamex Corp., Will Trade Under New Ticker "STEX" Starting September 12, 2025
➖ NeutralBenzinga•Sep 10, 2025, 03:55 PM
BioSig Technologies Enters Tokenized Yield Partnership With Monetary Metals
📈 PositiveBenzinga•Sep 8, 2025, 08:08 PM
Trading Halt: Halt status updated at 10:20:00 AM ET: Quotation Resumption: News and Resumption Times
➖ NeutralBenzinga•Sep 8, 2025, 02:20 PM
BioSig Technologies And Monetary Metals Announce Exclusive Long-Term Strategic Partnership To Launch Tokenized Gold Product Offering Up To 4% Yield
📈 PositiveBenzinga•Sep 8, 2025, 02:14 PM•Also: , ,
Trading Halt: Halted at 9:44:50 a.m. ET - Trading Halt: Halt News Pending
➖ NeutralBenzinga•Sep 8, 2025, 01:48 PM
Reported Earlier, BioSig Clarifies Proxy Filing Adjustments Do Not Impact Streamex Merger Closing Or Company Operations
➖ NeutralBenzinga•Sep 3, 2025, 06:35 AM
BioSig Technologies To Sell About 3.9M Shares Of Common Stock
➖ NeutralBenzinga•Aug 15, 2025, 09:37 PM
BioSig Technologies jumps 30% on $1.1B growth financing to launch gold-backed treasury along with Streamex
📈 PositiveSeeking Alpha•Jul 8, 2025, 08:49 AM•Also: , ,
Frequently Asked Questions about BSGM
What is BSGM's current stock price?
BioSig Technologies, Inc. (BSGM) is currently trading at $6.10 per share. The stock has moved +37.08% today.
What is the analyst price target for BSGM?
The average analyst price target for BSGM is $0.41, based on 1 analyst.
What sector is BioSig Technologies, Inc. in?
BioSig Technologies, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is BSGM's market cap?
BioSig Technologies, Inc. has a market capitalization of $0.19 billion, making it a small-cap company.
Does BSGM pay dividends?
No, BioSig Technologies, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorEYESW
Second Sight Medical Products Inc
$0.22
0LENZ
LENZ Therapeutics, Inc.
$18.00
Mkt Cap: $0.5B
LSB
LakeShore Biopharma Co., Ltd
$0.63
Mkt Cap: $0.0B
NVRO
Nevro Corp.
$5.84
Mkt Cap: $0.2B
SCTL
Societal CDMO, Inc.
$1.10
Mkt Cap: $0.1B
SPPI
Spectrum Pharmaceuticals, Inc.
$1.02
Mkt Cap: $0.2B
TCRT
Alaunos Therapeutics, Inc.
$3.56
Mkt Cap: $0.0B
THRX
Theseus Pharmaceuticals, Inc.
$4.07
Mkt Cap: $0.2B
VACC
Vaccitech plc
$5.00
Mkt Cap: $0.2B
ZVRA
Zevra Therapeutics, Inc.
$8.31
Mkt Cap: $0.5B
Explore stocks similar to BSGM for comparison